glutathione in parkinson's disease The system and its progression glutathione in parkinson's disease nebulized

No est permitido para uso humano con fines de investigacin

doi: 10.1093/jb/mvw098 377 MillsELKellyBONeillLAJ

## **Documentation requirements for J2350** As with any procedure, especially involving injecting drugs into patients, it's important to document the following before you file for a claim that includes this code: - The full name of the personnel who administered the injection + their credentials - The name and address of the facility where the injection was administered - The physician's order for this injection - The full name of the patient - The date and time of the drug administration by injection, including the NDC number of the injection - Patient records showing they have been diagnosed with a type of multiple sclerosis (e.g., primary progressive MS, relapse-remitting MS, etc.) - Patient records showing any other active disease - Patient records showing if they have an active infection - Patient records showing if the patient had clinical relapses of MS - Hepatitis B virus screening results (if this is the first dose

Melting Point and Description The melting point of oxidized glutathione is 196-198C

Injection Technique Subcutaneous injection guidance from clinical best-practice resources [13] [14] [15]